Having fallen short of earnings expectations in its third quarter, Allergan says non-GAAP earnings per share should see double-digit growth in the year ahead. Allergan offered some color on its outlook for the year ahead on Thursday, and according to at least one company follower, the cautiousness of CEO Brent Saunders ought to be well received after the company widely missed its third quarter earnings target.